EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokoll

Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects

Joy Shi, Magnus Løberg, Mette Kalager, Paulina Wieszczy, Nastazja D Pilonis, Hans-Olov Adami, Michal F Kaminski, Michael Bretthauer, Miguel A Hernán, The NordICC Study Group

European Journal of Epidemiology · 2025

DOI: 10.1007/s10654-025-01209-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Epidemiology, 2025. Verfasst von Joy Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, USA. joyshi@hsph.harvard.edu. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonoscopy, Early Detection of Cancer, Mass Screening. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Norges Forskningsråd, Helse Sør-Øst RHF, Narodowe Centrum Badań i Rozwoju.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We recently reported per-protocol estimates of colonoscopy screening on colorectal cancer incidence and mortality in NordICC, a large-scale randomized trial. Our results may be affected by residual confounding due to lack of detailed information on confounders. Here, we supplement our per-protocol analyses with instrumental variable (IV) estimates whose validity relies on an alternate set of assumptions but does not depend on the availability of confounder data. Individuals in the NordICC trial were randomized at a 1:2 ratio to receive either an invitation to a one-time screening colonoscopy (the invited group) or no invitation (the usual-care group). We used IV analyses to estimate bounds and point estimates of per-protocol effects of colonoscopy screening on colorectal cancer incidence and mortality after 10 years follow-up. Analyses included 28,220 participants in the invited group and 56,365 participants in the usual-care group. Participation in screening was 42%. In IV per-protocol analyses, the 10-year risk of colorectal cancer was 1.13% (95% confidence interval [CI]: 1.04, 1.23) with usual care and, depending on the assumptions, 0.66% (95% CI: 035, 0.95) to 0.74% (95% CI: 0.57, 0.95) in screened individuals (risk ratio of 0.59 [95% CI: 0.30, 0.98] to 0.65 [95% CI: 0.48, 0.87]). The risk of colorectal cancer mortality at 10 years was 0.29% (95% CI: 0.24, 0.33) in the usual-care group and 0.20 (95% CI: 0.09, 0.73) to 0.22% (95% CI: 0.08, 0.37) in the screened group (risk ratio of 0.71 [95% CI: 0.31, 2.89] to 0.79 [95% CI: 0.24, 1.42]). IV estimation of per-protocol effects suggests that colonoscopy screening reduces colorectal cancer incidence by 35 to 41% after 10 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsColonoscopyEarly Detection of CancerMass ScreeningHumansMaleFemaleMiddle AgedAgedIncidenceRisk Factors

Stichwörter der Autor:innen

ColonoscopyColorectal cancerInstrumental variablePer-protocolScreening

Autor:innen und Institutionen

  • CAUSALab, Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, USA. joyshi@hsph.harvard.edu.
  • Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
  • Clinical Effectiveness Research Group, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Medical Center for Postgraduate Education, Warsaw, Poland.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
  • Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway.

Förderung

  • Norges Forskningsråd
  • Helse Sør-Øst RHF
  • Narodowe Centrum Badań i Rozwoju
  • Polish-Norwegian Research Programme
  • Medical Center for Postgraduate Education, Poland
  • The Dutch Ministry of Health and Health Care Prevention (NL)
  • Swedish Cancer Foundation
  • Regionala Forskningsrådet Uppsala/Örebro

Zitieren

APA

Shi, J., Løberg, M., Kalager, M., Wieszczy, P., Pilonis, N. D., Adami, H. O., Kaminski, M. F., Bretthauer, M., Hernán, M. A., & The NordICC Study Group (2025). Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects. European Journal of Epidemiology. https://doi.org/10.1007/s10654-025-01209-w

Vancouver

Shi J, Løberg M, Kalager M, Wieszczy P, Pilonis ND, Adami HO, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects. European Journal of Epidemiology. 2025. doi:10.1007/s10654-025-01209-w

BibTeX
@article{Shi2025,
  author = {Shi, Joy and Løberg, Magnus and Kalager, Mette and Wieszczy, Paulina and Pilonis, Nastazja D and Adami, Hans-Olov and Kaminski, Michal F and Bretthauer, Michael and Hernán, Miguel A and The NordICC Study Group, The NordICC Study Group},
  title = {Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects},
  journal = {European Journal of Epidemiology},
  year = {2025},
  doi = {10.1007/s10654-025-01209-w}
}
Kostenlos starten →